Skip to main content
Premium Trial:

Request an Annual Quote

Regulus, UCSD to Collaborate on miRNA Treatments for Angiogenic Disease

Premium

Regulus Therapeutics said this week that it has begun collaborating with researchers at the University of California, San Diego, on microRNA-based treatments for angiogenic diseases.

The research will combine Regulus' miRNA platform with UCSD's expertise in animal models of angiogenesis, the company said.

According to Regulus, the effort will be funded by the UC Discovery Grant program, which supports collaborative research between the university and industry. Financial terms of the grant were not disclosed.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.